Wdr5 promotes metastasis and chemoresistance in prostate cancer: A novel therapeutic target

Wdr5 promotes metastasis and chemoresistance in prostate cancer: A novel therapeutic target

Bibliographic Details
Main Authors:	C. Xu, Z. Qianghua, P. Shengmeng, Z. Jingtong, H. Ming, L. Tianxin, H. Jian
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320338301

Similar Items

Gene expression profiling of WDR5 regulated genes in bladder cancer
by: Xu Chen, et al.
Published: (2015-09-01)

MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
by: Peng Xia, et al.
Published: (2021-07-01)

Targeting WDR5: A WINning Anti-Cancer Strategy?
by: Erin R Aho, et al.
Published: (2019-07-01)

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
by: Baotong Zhang, et al.
Published: (2021-03-01)

DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
by: Jinyu Zhang, et al.
Published: (2020-09-01)

YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells
by: Yi‐Fang Yang, et al.
Published: (2019-07-01)

miR-134-5p Promotes Stage I Lung Adenocarcinoma Metastasis and Chemoresistance by Targeting DAB2
by: Liang Zhang, et al.
Published: (2019-12-01)

WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells
by: Simona Punzi, et al.
Published: (2019-11-01)

miR-103 promotes endothelial maladaptation by targeting lncWDR59
by: Lucia Natarelli, et al.
Published: (2018-07-01)

Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
by: Jingtong Zhang, et al.
Published: (2021-06-01)

Cbx8 Acts Non-canonically with Wdr5 to Promote Mammary Tumorigenesis
by: Chi-Yeh Chung, et al.
Published: (2016-07-01)

ALKBH4 Functions as a Suppressor of Colorectal Cancer Metastasis via Competitively Binding to WDR5
by: Chaoqin Shen, et al.
Published: (2020-05-01)

BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance
by: Ferretti, Roberta, et al.
Published: (2017)

Moonlighting with WDR5: A Cellular Multitasker
by: Alissa duPuy Guarnaccia, et al.
Published: (2018-01-01)

WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma
by: Huang D, et al.
Published: (2020-10-01)

Synergistic effect of SRY and its direct target, WDR5, on Sox9 expression.
by: Zhen Xu, et al.
Published: (2012-01-01)

WDR74 promotes proliferation and metastasis in colorectal cancer cells through regulating the Wnt/β-catenin signaling pathway
by: Cai Zhou, et al.
Published: (2021-09-01)

The role of CTGF in chemoresistance and metastasis of osteosarcoma
by: Hsiao-Chi Tsai, et al.
Published: (2014)

The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
by: Qi Zhang, et al.
Published: (2020-05-01)

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.
by: Jingli Hao, et al.
Published: (2012-01-01)

WDR5 Expression Is Prognostic of Breast Cancer Outcome.
by: Xiaofeng Dai, et al.
Published: (2015-01-01)

Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
by: Li, X., et al.
Published: (2022)

Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis
by: Jacob Insua‐Rodríguez, et al.
Published: (2018-10-01)

miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer
by: Cai Z, et al.
Published: (2020-01-01)

The role of WDR72 in amelogenesis
by: Husein, Dina R.
Published: (2019)

SPOCK1 promotes tumor growth and metastasis in human prostate cancer
by: Chen Q, et al.
Published: (2016-07-01)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
by: Lynn Roy, et al.
Published: (2018-07-01)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
by: Xiaojie Feng, et al.
Published: (2019-06-01)

Identification of target genes of SMAD4 signaling network inhibit pancreatic tumor metastasis and chemoresistance
by: Sz-yang Huang, et al.
Published: (2010)

The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer
by: Kebin Lu, et al.
Published: (2018-11-01)

Identification of metastasis-driving genes as potential therapeutic targets/ biomarkers for metastatic prostate cancer
by: Chiang, Yan Ting
Published: (2015)

Fragment screening for a protein-protein interaction inhibitor to WDR5
by: Matthew L. Dennis, et al.
Published: (2019-11-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
by: Weiguang Liu, et al.
Published: (2019-09-01)

Subcellular localization of p44/WDR77 determines proliferation and differentiation of prostate epithelial cells.
by: Shen Gao, et al.
Published: (2012-01-01)

The HINT1 and HINTW responsive element(s) in WDR36 proximal promoter region
by: Ling-Yi Huang, et al.
Published: (2009)

WDR45 Mutation Impairs the Autophagic Degradation of Transferrin Receptor and Promotes Ferroptosis
by: Qiuhong Xiong, et al.
Published: (2021-05-01)

Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer
by: Yaqing Li, et al.
Published: (2020-06-01)

Regulation of DNA replication and chromosomal polyploidy by the MLL-WDR5-RBBP5 methyltransferases
by: Fei Lu, et al.
Published: (2016-10-01)

The use of prostate specific antigen (PSA) promoter as a therapeutic target for prostate cancer
by: Yuan-Kui Zhen, et al.
Published: (2001)

NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer
by: Hsin-Hua Chung, et al.
Published: (2020-07-01)